Applications are now open. The application deadline is 21 January 2022
To address this concern, we
aim to design a comprehensive screen test for national population genetic
screening. This will include ~400-450 genes associated with genetic diseases
found at an increased frequency in the different populations in the Middle East
and will identify pathogenic variants. As a result, there is an opportunity to
use screening to identify these otherwise healthy individuals and consider
implementing clinical interventions early, thereby reducing the risk of
undesirable outcomes caused by missed or late diagnoses. In addition, because
many of these disorders are inherited in autosomal recessive or X-linked
manners, patients may be at risk of passing on a genetic disorder to their
children without knowing it.
